High-shear granulation as a manufacturing method for cocrystal granules.

Current research in pharmaceutical formulation has focused on methods to improve the mechanical and dissolution properties of active pharmaceutical ingredients (APIs). While cocrystal formation offers a promising approach to tailor these properties, large-scale manufacturing techniques remain underdeveloped. Prior studies have demonstrated the potential of cocrystals to enhance solubility and stability, but few have explored scalable production methods. This gap motivated the investigation of high-shear wet granulation as a feasible route for cocrystal granule manufacturing. No prior work had resolved whether this method could consistently produce stable and functional cocrystal granules. Existing knowledge suggests that excipient selection and process parameters significantly influence granule properties. However, the specific impact of these variables on cocrystal formation and stability remains unclear. This study aimed to address that uncertainty by examining the feasibility of high-shear wet granulation for cocrystal production. The findings could help bridge the gap between cocrystal research and industrial application.

This study aimed to assess the suitability of high-shear wet granulation as a scalable manufacturing method for cocrystal granules. The researchers focused on evaluating the influence of formulation and process parameters on cocrystal formation and granule properties. A specific problem addressed was the lack of a validated large-scale technique for producing cocrystal-based drug products. The motivation stemmed from the potential of cocrystals to improve drug performance through tailored physicochemical properties. The study sought to determine whether high-shear wet granulation could consistently produce cocrystal granules with acceptable mechanical and dissolution characteristics. It also aimed to investigate how excipient choice and process variables affect cocrystal stability and functionality. The researchers hypothesized that granulation parameters such as liquid content, impeller speed, and excipient type could be optimized to yield stable cocrystal granules. This work contributes to the broader goal of integrating cocrystal technology into pharmaceutical manufacturing practices.

The researchers employed high-shear wet granulation to produce cocrystal granules on a batch scale. They varied parameters such as granulation liquid exposure time, liquid volume, and impeller speed to assess their impact on cocrystal formation. Different excipients, including hydroxypropyl cellulose, microcrystalline cellulose, and calcium hydrogenphosphate, were used to evaluate their influence on granule properties. The granules were analyzed for mechanical characteristics and dissolution behavior. The study design included controlled variations in process and formulation variables to isolate their effects. Characterization techniques focused on mechanical strength and drug release profiles. The researchers also examined storage stability under varying humidity conditions. This approach allowed them to identify key factors influencing cocrystal formation and granule performance.

High-shear wet granulation was found to be a feasible method for producing cocrystal granules. The formation of cocrystals was influenced by the duration of exposure to granulation liquid, the volume of liquid used, and the impeller speed. Excipient choice played a critical role, with calcium hydrogenphosphate affecting stability under high humidity conditions. The presence of calcium hydrogenphosphate led to the formation of calcium tartrate monohydrate, a poorly soluble salt. Cocrystal formation increased compactability compared to reference granules containing piracetam and excipients. However, drug release was slightly reduced, likely due to the lower solubility of the cocrystal. In formulations containing calcium hydrogenphosphate, no significant differences in compactability or drug release were observed between cocrystal and reference granules. These results suggest that excipient selection is a key factor in determining the performance of cocrystal granules.

The authors concluded that high-shear wet granulation is a viable but complex method for manufacturing cocrystal granules. The study demonstrated that cocrystal formation can influence compactability and drug release, which may affect drug performance. These findings suggest that cocrystal formation should be investigated during pre-formulation stages. The results highlight the importance of excipient selection in determining granule stability and functionality. The presence of calcium hydrogenphosphate was shown to impact storage stability, particularly under high humidity conditions. The researchers propose that process parameters such as liquid exposure time and impeller speed can be optimized to enhance cocrystal formation. The observed differences in drug release and compactability suggest that cocrystal properties can be tailored through formulation adjustments. These conclusions align with the study's objective of evaluating the feasibility of high-shear wet granulation for cocrystal production.